Skip to content
← Full study record

NCT01167712 · MORE INFO

Limitations, agreements, and source contact

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · Source last updated 2026-05-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
lgedeon@gogstats.org
organization
NRG Oncology
phone
716-845-1169
title
Linda Gedeon for Mark Brady, PhD.
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
lgedeon@gogstats.org
organization
NRG Oncology
phone
716-845-1169
title
Linda Gedeon for Mark Brady, PhD.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice